Scientists closer to shot for kala azar

Image
IANS Sydney
Last Updated : Apr 22 2013 | 2:44 PM IST

The black fever parasite migrates to organs such as liver, spleen and bone marrow and if left untreated will almost always be fatal.

Symptoms of the disease, known as kala azar in India, include fever, weight loss, mucosal ulcers, fatigue, anaemia and substantial swelling of the liver and spleen.

Leishmaniasis affects 12 million people and there are an estimated 1.5 million new cases annually, mainly in India, Bangladesh, Nepal, Sudan, South Sudan, Ethiopia and Brazil, the journal Nature Genetics reports.

Jenefer Blackwell, professor and head of genetics at the Telethon Institute for Child Health Research, University of Western Australia co-authored the study which has uncovered a single major genetic risk factor for visceral leishmaniasis.

Scientists from India, Brazil, Britain, US and Australia, Blackwell identified variation in a specific region of the major immune response locus, known to immunologists as the major histocompatibility complex (MHC), as the single most important genetic risk factor for disease, according to an university statement.

The researchers compared genomes of 1,346 people suffering from disease in India and Brazil against those of 2702 healthy controls.

The findings were confirmed in an independent cohort of 941 cases and 990 healthy controls (not suffering from black fever) from India.

Teams in Australia, Britain and the US are using the results to study the way the immune system interacts with the disease in mice.

"Earlier genetic studies of visceral leishmaniasis in inbred mice allowed us to clearly demonstrate the importance of the MHC in regulating this disease," Blackwell said.

 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 15 2013 | 11:30 AM IST

Next Story